DAIGNEAULT ALESSANDRA (General Counsel & Secretary) sold 33.72K shares of NRX PHARMACEUTICALS, INC. on the open market

Open‑market sale worth $442.0K. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale

DAIGNEAULT ALESSANDRA

Filed: 11/2/2021ACC: 0000950142-21-003504

InsiderDAIGNEAULT ALESSANDRACIK 1864648

→

IssuerNRX PHARMACEUTICALS, INC.CIK 1719406

Officer· General Counsel & Secretary

Since May 2021

-33.72K

Net shares

Net seller

$442.0K

Total sold

Open market trades

0B · 1S

Total transactions

92.58K acquired · 126.30K disposed

Non-Derivative Transactions4

Common Stock

Direct

M · Option Exercise

+27.39K

Price / share

$3.07

Trade value

$84.10K

% of position

433.5%

8/19/2021

6.32K→33.72K

Common Stock

Direct

S · Sale

−33.72K

Price / share

$13.11

Trade value

$442K

% of position

New position

8/23/2021

33.72K→0.00

Common Stock

Direct

M · Option Exercise

+18.42K

Price / share

$3.07

Trade value

$56.55K

% of position

New position

9/2/2021

0.00→18.42K

Common Stock

Direct

M · Option Exercise

+13.16K

Price / share

$3.07

Trade value

$40.41K

% of position

71.5%

9/2/2021

18.42K→31.58K

Total

Net shares

+25.26K

Net value

-$260.94K

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Direct	8/19/2021	M · Option Exercise	+27.39K	$3.07	$84.10K	433.5%	6.32K	33.72K
Common Stock Direct	8/23/2021	S · Sale	−33.72K	$13.11	$442K	New position	33.72K	0.00
Common Stock Direct	9/2/2021	M · Option Exercise	+18.42K	$3.07	$56.55K	New position	0.00	18.42K
Common Stock Direct	9/2/2021	M · Option Exercise	+13.16K	$3.07	$40.41K	71.5%	18.42K	31.58K
Total			+25.26K		-$260.94K

Derivative Transactions6

Employee Stock Option (Right to buy)

Direct

C · Conversion

Converts to

Common Stock

43K shares

−43K

Strike price

3.07

Held after

100.84K

Exercisable

—

8/19/2021

Restricted Stock Units

Direct

A · Award

Converts to

Common Stock

15.61K shares

+15.61K

Strike price

Held after

15.61K

Exercisable

—

8/19/2021

Employee Stock Option (Right to buy)

Direct

C · Conversion

Converts to

Common Stock

28.92K shares

−28.92K

Strike price

3.07

Held after

71.92K

Exercisable

—

9/2/2021

Employee Stock Option (Right to buy)

Direct

C · Conversion

Converts to

Common Stock

20.67K shares

−20.67K

Strike price

3.07

Held after

28.93K

Exercisable

—

9/2/2021

Restricted Stock Units

Direct

A · Award

Converts to

Common Stock

10.50K shares

+10.50K

Strike price

Held after

26.10K

Exercisable

—

9/2/2021

Restricted Stock Units

Direct

A · Award

Converts to

Common Stock

7.50K shares

+7.50K

Strike price

Held after

33.60K

Exercisable

—

9/2/2021

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Employee Stock Option (Right to buy) Direct	Common Stock43K shares	8/19/2021	C · Conversion	−43K	3.07	—	100.84K
Restricted Stock Units Direct	Common Stock15.61K shares	8/19/2021	A · Award	+15.61K		—	15.61K
Employee Stock Option (Right to buy) Direct	Common Stock28.92K shares	9/2/2021	C · Conversion	−28.92K	3.07	—	71.92K
Employee Stock Option (Right to buy) Direct	Common Stock20.67K shares	9/2/2021	C · Conversion	−20.67K	3.07	—	28.93K
Restricted Stock Units Direct	Common Stock10.50K shares	9/2/2021	A · Award	+10.50K		—	26.10K
Restricted Stock Units Direct	Common Stock7.50K shares	9/2/2021	A · Award	+7.50K		—	33.60K